Company Description

Cellcentric is an innovative biotechnology company that has developed Inobrodib, a new type of treatment for people with cancer, and multiple myeloma in particular. It is a small molecule drug that targets p300/CBP, lowering the expression of key cancer drivers, MYC and IRF4.